IGM Biosciences Inc (IGMS)
1.24
-0.04
(-3.12%)
USD |
NASDAQ |
Mar 28, 16:00
1.24
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Total Liabilities (Quarterly): 217.54M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | 134.52M |
| Biomea Fusion Inc | 34.45M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.69M |
| Theriva Biologics Inc | 16.28M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.71M |
| Shareholders Equity (Quarterly) | 48.17M |
| Current Ratio | 5.144 |